News & Analysis as of

Pradaxa and Actos: Is Non-Preservation of Documents an Emerging Trend?

When a US District Court judge fined Boehringer Ingelheim almost $1 million at the end of last year for failure to preserve documents regarding the blood thinner Pradaxa, the decision served as a precursor to a similar...more

Boehringer Ingelheim to Pay $650M to Settle Pradaxa Claims

German drugmaker to settle about 4,000 plaintiff’s Pradaxa claims for $650M. Claimants’ Negotiating Counsel achieved a $650M Settlement in In Re Pradaxa (Dabigatran Etexilate) Products Liability Litigation, MDL No. 2385,...more

2 Results
|
View per page
Page: of 1